Lotte
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Lotte (Lotte Holdings) is a holding company, a firm whose core purpose is to own controlling stakes in other businesses rather than operating those businesses directly.
It is listed on KOSPI, South Korea's main stock exchange. The company earns its revenue primarily from dividends paid by its subsidiaries, fees charged to those subsidiaries for the use of the Lotte brand name, and rental income. It currently holds controlling stakes in nineteen domestic subsidiaries, including Lotte Shopping, Lotte Chemical, Lotte Wellfood, and Lotte Chilsung Beverage.
Summary is AI-generated and may contain errors · figures from DART filings
Lotte is a pure holding company formed through a split-merger of several operating affiliates, meaning investors hold a stake in the group's corporate apex rather than in any single operating business.
Lotte in five facts
What does Lotte do?
Lotte (Lotte Holdings) is a holding company, a firm whose core purpose is to own controlling stakes in other businesses rather than operating those businesses directly.
Where is Lotte listed and in which sector?
Lotte (Korean name: 롯데지주) trades under KRX code 004990 on KOSPI, the main board of the Korea Exchange. It is classified in the Financials sector, Diversified Financials.
How large is Lotte?
Its market capitalisation was US$1.7B on 2026-10-21, which puts it in this site's large-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Lotte's latest annual revenue and operating profit?
For fiscal year 2025, Lotte reported revenue of US$11.7B, operating profit of US$180.7M and a net loss of US$449.1M, per its annual report on DART (data retrieved from DART on 2026-09-06). Revenue was down 1.4% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-06
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Decision to guarantee a third party's debt (subsidiary)Sep 30
- Material event reportSep 28
- Material event reportSep 28
- Decision to acquire shares/equity in another company (subsidiary)
Lotte disclosed a subsidiary's acquisition, worth US$435M.
M&A · Sep 17 - Decision to guarantee a third party's debt (subsidiary)Sep 17
- Securities issuance reportSep 3
- ProspectusSep 3
- [Amended] Decision to guarantee a third party's debt (subsidiary)Sep 2
- [Terms finalized] Securities registration statement (debt)Sep 2
- [Amended] Securities registration statement (debt)Sep 2
- [Amended] Decision to guarantee a third party's debt (subsidiary)Sep 1
- Cash/in-kind dividend decision (subsidiary)
Lotte Corporation's subsidiary Lotte Chemical Corp. decided on 2026-08-20 to pay an interim cash dividend of US$0.36 per common share, totaling US$15.2M, with a record date of 2026-09-03 and payment scheduled for 2026-09-18.
Dividend · Aug 20 - [Amended] Rights offering (paid-in capital increase) decision (subsidiary)
Lotte Corporation amended its July 6, 2026 disclosure on subsidiary Lotte Biologics Co., Ltd.'s rights offering after the subscription period closed, reducing the new shares from 4,209,000 to 4,208,111 common shares and the facility-fund use of proceeds from US$183,571,583 to US$183,532,810, with 889 forfeited shares left unissued; the US$43.61-per-share rights offering (payment date 2026-08-19) funds construction of Lotte Biologics' Songdo Bio Campus Plant 1.
Capital raise · Aug 20 · 2 versions - Cash/in-kind dividend decision (subsidiary)Dividend · Jun 11
- Material event report (spin-off) (subsidiary)M&A · Mar 26
- [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Lotte updated its previously filed consolidated results for FY2025: revenue of US$10.5B (−1.4% year on year), operating profit of US$161M (−29.7% year on year) and a net loss of US$401M.
Earnings · Mar 9 · 2 versions - [Amended] Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary)
Lotte updated its previously filed a subsidiary's consolidated results for FY2025: revenue of US$12.5B (−7.1% year on year), an operating loss of US$636M and a net loss of US$1.67B.
Earnings · Mar 4 · 2 versions - Cash/in-kind dividend decision
Lotte declared a cash dividend of US$0.85 per share.
Dividend · Feb 9 - Cash/in-kind dividend decision (subsidiary)Dividend · Feb 5
- Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary)
Lotte reported a subsidiary's consolidated results for FY2025: revenue of US$9.41B (−1.8% year on year), operating profit of US$375M (+15.6% year on year) and net income of US$50.4M (from a loss a year earlier).
Earnings · Feb 5 - Cash/in-kind dividend decision (subsidiary)Dividend · Feb 4
- Cash/in-kind dividend decision (subsidiary)Dividend · Feb 4
- Change of 30% or more in revenue or profit/loss structure (15% for large companies) (subsidiary)Earnings · Feb 2